LMO7 was the only protein next to H2AFY found to display changes in protein level following FFA treatment, being differentially expressed at the mRNA level in HCC patients and exhibiting a significant difference in the survival rate (although in an opposite direction). The gene discussed is LMO7; the disease is hepatocellular carcinoma.